ArticleBMC public health2025
Prevalence of hyperglycaemia, prediabetes and type-2 diabetes mellitus in the adult Lebanese population: results of the PREDICT study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe literature on the prevalence of glycaemia dysregulation among Lebanese adults is inconclusive.
methodsThe PREDICT study was a national cross-sectional study that aimed to report the prevalence of incidental hyperglycaemia, prediabetes or type-2 diabetes mellitus (DM) in Lebanese adults. Glycaemia was measured by blood glucose finger prick test and data on demographic, medical history and lifestyle were collected.
resultsOut of 10,448 subjects included in the analysis, 2785 belonged to the prediabetes group (Group P), with 93 subjects (0.9%) reporting a prior diagnosis of prediabetes and 2692 (25.8%) with study-determined glycaemia in the prediabetes range. Additionally, 1135 subjects (10.9%) reported a prior diagnosis of type-2 DM and 640 (6.1%) had study-determined glycaemia in the type-2 DM range, making up 1775 subjects in the type-2 DM group (Group D). Hyperglycaemia significantly increased with age, and was detected in elderly (58.5%), older adults (46.3%) and younger adults (33.0%), p < 0.0001. Subjects with normal glycaemia were 43.7 ± 15.2 years old; while age in group P was 46.4 ± 15.6 years and in group D it was 57.6 ± 14.6 years (p < 0.001). Group P subjects had a body mass index (BMI) of 26.7 ± 4.6 kg/m
conclusionsIn this study, 10% of subjects had a prior diagnosis of type-2 DM. Alarmingly, 6% and 26% of subjects had incidentally-detected hyperglycaemia in the type-2 DM and prediabetes range, respectively. The prevalence of hyperglycaemia and of prediabetes that might progress to type-2 DM poses a serious threat to the Lebanese population and healthcare system; especially among younger and seemingly healthy adults. Hence, this study shed the light on potentially undiagnosed cases of glycaemia disorders, urging the need for early detection and timely management to curb the medical, social and health burden of type-2 DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.